Publication | Open Access
<p>PD-1/PD-L1 Inhibitor Combined with Chemotherapy Can Improve the Survival of Non-Small Cell Lung Cancer Patients with Brain Metastases</p>
15
Citations
31
References
2020
Year
ICIs combined with chemotherapy demonstrated survival benefits over ICI monotherapy in patients with NSCLCs and BMs.
| Year | Citations | |
|---|---|---|
Page 1
Page 1